文献速递眼底病与葡萄膜炎

二肽基肽酶4作为一种新型脂肪因子损害2型糖尿病患者的视网膜微循环

Dipeptidyl Peptidase 4, a Novel Adipokine, Impairs Retinal Microcirculation in Patients With Type 2 Diabetes Mellitus.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究纳入67例伴有极轻度糖尿病视网膜病变的2型糖尿病患者并按性别分组,比较激光多普勒测速测得的视网膜循环参数与血清DPP4浓度,并在离体视网膜小动脉上观察DPP4孵育前后的内皮功能。男性中血浆DPP4浓度与视网膜血管直径及视网膜血流量呈负相关,女性中未见此相关;离体实验中腔内DPP4处理以剂量依赖方式显著减弱内皮依赖性NO介导的血管舒张。

要点

  • 男性2型糖尿病早期DR患者中,血浆DPP4浓度与视网膜血管直径和视网膜血流量呈负相关。
  • 女性患者中未观察到血浆DPP4浓度与视网膜血管直径或视网膜血流量的相关性。
  • 离体视网膜小动脉中,DPP4以剂量依赖方式减弱内皮依赖性NO介导的血管舒张。

核心结论

  • 作者认为,在伴有早期DR的男性2型糖尿病患者中,高血清DPP4浓度可能与视网膜血流量降低相关,可能通过血管直径收缩实现。
  • 作者认为,DPP4可能通过NADPH氧化酶产生超氧化物,抑制视网膜小动脉内皮依赖性NO介导的舒张。

研究设计与样本

  • 研究纳入67例伴有极轻度糖尿病视网膜病变的2型糖尿病患者,按性别分为两组。
  • 采用激光多普勒测速仪测量患者视网膜循环参数,并测定血清DPP4浓度进行比较。
  • 离体实验使用分离的视网膜小动脉,比较DPP4孵育前后的视网膜内皮功能。

主要发现

  • 男性中血浆DPP4浓度与视网膜血管直径及视网膜血流量呈负相关,女性中未见此相关。
  • 多元回归分析显示血浆DPP4水平与血管直径独立且负相关。
  • 离体实验中,腔内DPP4处理以剂量依赖方式显著减弱内皮依赖性NO介导的血管舒张。
  • 超氧化物清除剂TEMPOL、NADPH氧化酶抑制剂夹竹桃麻素和DPP4抑制剂替格列汀均可预防DPP4诱导的视网膜内皮功能障碍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The study objective was to examine the role of dipeptidyl peptidase 4 (DPP4) on retinal microcirculation in patients with type 2 diabetes mellitus (DM) and an in vitro study. METHODS: Sixty-seven patients with type 2 diabetes and minimal diabetic retinopathy (DR) were divided into two groups based on gender. We compared the patients' retinal circulatory parameters measured with laser Doppler velocimetry and serum DPP4 concentrations. Using isolated retinal arterioles, we also compared the retinal endothelial function before and after DPP4 incubation. RESULTS: The plasma DPP4 concentrations were correlated negatively with the retinal vessel diameter (D) and retinal blood flow (RBF) in men but not women. Multiple regression analysis showed that the plasma DPP4 level was independently and negatively correlated with the vessel D. In vitro, intraluminal DPP4 treatment significantly attenuated endothelium-dependent nitric oxide (NO)-mediated vasodilation with a dose-dependent manner. Superoxide scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL), the NADPH oxidase inhibitor apocynin, and the DPP4 inhibitor teneligliptin, prevented the retinal endothelial dysfunction induced by DPP4. CONCLUSIONS: Our results indicated that high serum DPP4 concentration may be associated with decreased RBF, probably via the constricted vessel D in men with type 2 diabetes with early-phase DR and further that DPP4 may inhibit endothelium-dependent NO-mediated dilation in the retinal arterioles via producing superoxide from NADPH oxidase.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Omae T, Ono S, Kamiya T, et al. Dipeptidyl Peptidase 4, a Novel Adipokine, Impairs Retinal Microcirculation in Patients With Type 2 Diabetes Mellitus. Invest Ophthalmol Vis Sci. 2025. PMID: 41182027. doi:10.1167/iovs.66.14.4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。